Last Updated: May 25, 2026

Suppliers and packagers for crenessity


✉ Email this page to a colleague

« Back to Dashboard


crenessity

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Neurocrine CRENESSITY crinecerfont CAPSULE;ORAL 218808 NDA Neurocrine Biosciences, Inc. 70370-5025-1 60 CAPSULE in 1 BOTTLE (70370-5025-1) 2024-12-13
Neurocrine CRENESSITY crinecerfont CAPSULE;ORAL 218808 NDA Neurocrine Biosciences, Inc. 70370-5050-1 60 CAPSULE in 1 BOTTLE (70370-5050-1) 2024-12-13
Neurocrine CRENESSITY crinecerfont CAPSULE;ORAL 218808 NDA Neurocrine Biosciences, Inc. 70370-5100-1 30 CAPSULE in 1 BOTTLE (70370-5100-1) 2024-12-13
Neurocrine CRENESSITY crinecerfont SOLUTION;ORAL 218820 NDA Neurocrine Biosciences, Inc. 70370-5250-1 30 mL in 1 BOTTLE (70370-5250-1) 2024-12-13
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for crenessity

Last updated: May 2, 2026

Who Supplies the “CRENESSITY” Pharmaceutical Drug?

No reliable, citable data identifies a marketed pharmaceutical product named CRENESSITY, nor do public patent, regulatory, or catalog sources link that name to a specific active ingredient, sponsor/marketing authorization holder, or verified supply chain. As a result, no defensible supplier roster can be produced for “CRENESSITY” without manufacturing or regulatory identifiers (active ingredient, INN/USAN, brand-to-API mapping, MAH, labeler, or dossier references).

What supplier list can be built for “CRENESSITY”?

None.

Does “CRENESSITY” appear as an API, brand, or MAH in public records?

No citable linkage is available in the public domain to support:

  • API supplier identification
  • contract manufacturing organization (CMO) identification
  • finished-dose manufacturer identification
  • marketing authorization holder (MAH) identification
  • parallel trade labeler identification

What name variants would typically unlock supplier data?

No defensible basis exists here because “CRENESSITY” does not map to a confirmed INN/brand/API entry in the records needed for supplier attribution.


Key Takeaways

  • A supplier list cannot be produced for “CRENESSITY” because no verifiable public record ties that name to a specific drug product or active ingredient.
  • Without an authoritative drug identity (API/INN, MAH, or labeler), supplier attribution would be speculative rather than patent-analyst actionable.

FAQs

1) Who manufactures CRENESSITY?

No verified manufacturer can be listed from public, citable sources.

2) Who supplies the active ingredient for CRENESSITY?

No verified API supplier can be listed from public, citable sources.

3) Are there contract manufacturers (CMOs) tied to CRENESSITY?

No verified CMO links can be produced for “CRENESSITY.”

4) What regulatory authority records identify CRENESSITY?

No citable regulatory record mapping “CRENESSITY” to a specific product identity is available.

5) Can supplier data be derived from patents for CRENESSITY?

No, because “CRENESSITY” cannot be tied to a specific patent family or product identity with citable public linkage.


References

No sources cited.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.